表紙:気管支内超音波生検の世界市場(2021年~2028年)
市場調査レポート
商品コード
1037915

気管支内超音波生検の世界市場(2021年~2028年)

Global Endobronchial Ultrasound Biopsy Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.01円
気管支内超音波生検の世界市場(2021年~2028年)
出版日: 2021年11月24日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

気管支内超音波検査は、胸部のリンパ節が腫れている肺がんや感染症、その他の疾患を診断するための低侵襲でありながら効果の高い検査方法です。EBUSでは気管支鏡のツールを使用して行うため、この検査では胸部に外科的な切り傷をつけることはありません。

EBUS装置の技術的進歩、低侵襲手術に対する消費者の嗜好、結核などの呼吸器系疾患の増加、肺がん患者数の増加などが市場成長を促進する要因となっています。ただし、気管支内超音波生検に関連する合併症が市場成長の妨げになると予想されています。

当レポートは、世界の気管支内超音波生検市場について調査しており、市場規模、機会や影響、成長および抑制要因、COVID-19による影響、製品タイプ・アプリケーション・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 世界の気管支内超音波生検市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界の気管支内超音波生検市場-市場の定義と概要

第3章 世界の気管支内超音波生検市場-エグゼクティブサマリー

  • 製品タイプ別の市場内訳
  • アプリケーション別の市場内訳
  • エンドユーザー別の市場内訳
  • 地域別の市場内訳

第4章 世界の気管支内超音波生検市場-市場力学

  • 市場に影響を与える要因
    • 成長要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の気管支内超音波生検市場-業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 世界の気管支内超音波生検市場-COVID-19分析

  • Covid-19の市場に対する影響分析
    • COVID-19前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後または将来のシナリオ
  • Covid-19における価格のダイナミクス
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の気管支内超音波生検市場-製品タイプ別

  • イントロダクション
    • 製品タイプ別の市場規模分析、および前年比成長分析(%)
    • 製品タイプ別の市場魅力指数
  • 経気管支吸引針
    • イントロダクション
    • 市場規模分析、百万米ドル、2019年~2028年および前年比成長分析(%)、2020年~2028年
  • 生検針
  • 生検鉗子
  • 他の

第8章 世界の気管支内超音波生検市場-アプリケーション別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%)、アプリケーション別
    • アプリケーション別の市場魅力指数
  • 肺がんの診断
    • イントロダクション
    • 市場規模分析、百万米ドル、2019年~2028年および前年比成長分析(%)、2020年~2028年
  • 肺感染症の診断
  • 他の

第9章 世界の気管支内超音波生検市場-エンドユーザー別

  • イントロダクション
    • エンドユーザー別の市場規模分析、および前年比成長分析(%)
    • エンドユーザー別の市場魅力指数
  • 病院
    • イントロダクション
    • 市場規模分析、百万米ドル、2019年~2028年および前年比成長分析(%)、2020年~2028年
  • 診断研究所
  • その他

第10章 世界の気管支内超音波生検市場-地域別

  • イントロダクション
    • 市場規模分析、百万米ドル、2019年~2028年および前年比成長分析(%)、2020年~2028年、地域別
    • 地域別の市場魅力指数
  • 北米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 製品タイプ別の市場規模分析、および前年比成長分析(%)
    • アプリケーション別の市場規模分析、および前年比成長分析(%)
    • エンドユーザー別の市場規模分析、および前年比成長分析(%)
    • 国別の市場規模分析、および前年比成長分析(%)
  • 欧州
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 製品タイプ別の市場規模分析、および前年比成長分析(%)
    • アプリケーション別の市場規模分析、および前年比成長分析(%)
    • エンドユーザー別の市場規模分析、および前年比成長分析(%)
    • 国別の市場規模分析、および前年比成長分析(%)
  • 南米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 製品タイプ別の市場規模分析、および前年比成長分析(%)
    • アプリケーション別の市場規模分析、および前年比成長分析(%)
    • エンドユーザー別の市場規模分析、および前年比成長分析(%)
    • 国別の市場規模分析、および前年比成長分析(%)
  • アジア太平洋地域
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 製品タイプ別の市場規模分析、および前年比成長分析(%)
    • アプリケーション別の市場規模分析、および前年比成長分析(%)
    • エンドユーザー別の市場規模分析、および前年比成長分析(%)
    • 国別の市場規模分析、および前年比成長分析(%)
  • 中東・アフリカ
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 製品タイプ別の市場規模分析、および前年比成長分析(%)
    • アプリケーション別の市場規模分析、および前年比成長分析(%)
    • エンドユーザー別の市場規模分析、および前年比成長分析(%)

第11章 世界の気管支内超音波生検市場-競合情勢

  • 主要動向と戦略
  • 企業シェア分析
  • 製品のベンチマーク

第12章 世界の気管支内超音波生検市場-企業プロファイル概要

  • Olympus Corporation
    • 会社概要
    • 製品ポートフォリオ・概要
    • 主なハイライト
    • 財務概要
  • Medtronic plc
  • CLINODEVICE
  • CONMED Corporation
  • Medi-Globe Corporation
  • Boston Scientific Corporation
  • Veran Medical Technologies
  • Simbionix USA Corporation
  • FUJIFILM Corporation
  • Cook Group Incorporated

第13章 世界の気管支内超音波生検市場-DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMMI4308

Market Overview

The global endobronchial ultrasound biopsy market size was valued at US$ XX million in 2020 and is estimated to reach US$ XX million by 2028,growing at a high CAGR of XX % during the forecast period (2021-2028).

Endobronchial ultrasound is a minimally invasive but highly effective procedure for diagnosing lung cancer, infections, and other diseases with enlarged lymph nodes in the chest.An EBUS uses a bronchoscope tool to do this, and no surgical cuts will be made in the chest for this procedure.

Market Dynamics

The factors driving the market growth are technological advancements in EBUS devices, consumer preference for minimally invasive surgeries, the rising prevalence of respiratory diseases such as tuberculosis, and the high number of people who have lung cancer are all contributing factors.

Technological advancements in EBUS devices is expected to drive the global endobronchial ultrasound biopsy market in the forecast period

Over the last decades, technological advancements have enabled pulmonologists to perform endobronchial ultrasounds (EBUS). The multilayered structure of the tracheobronchial wall can be analyzed better with an EBUS mini-probe than with any other imaging modality. It can be used to biopsy peripheral lesions instead of fluoroscopic guided biopsy. For mediastinal lymph node staging of lung cancer, EBUS-transbronchial needle aspiration has proven useful.Other than EBUS RP, new techniques have emerged in the last decade to help guide and biopsy PPLs(peripheral pulmonary lesions)through the tracheobronchial tree during bronchoscopy. Virtual bronchoscopy (VB) and electromagnetic navigation bronchoscopy (ENB) can generate a virtual image for biopsy. ENB provides approach directions in real-time. When ENB or VB are used for biopsy, the diagnostic yield is comparable to EBUS RP guidance biopsy. However, the diagnostic yield increases significantly when two combined methods, such as EBUS RP + ENB or EBUS RP + VB. Another tool for improving diagnostic accuracy is ultrathin bronchoscopy. It has a 3.0 mm diameter and includes a working channel.

The other method which is expected to drive the market is the ROSE of EBUS-TBNA. It is a well-established tool for improving procedure yield. Rapid on-site evaluation in conjunction with TBNA reduces the cytopathology laboratory's workload by significantly reducing pulmonologists' total number of slides compared to samples without ROSE. Most importantly, ROSE results in better patient care. When ROSE is used, different clinical trials and large series have reported lower complication rates.

For example, on February 25, 2021, Rela Hospital in Chennai launched EBUS (Endobronchial Ultrasound) Bronchoscopy. It is one of the city's few that has this technology. The hospital carries out EBUS bronchoscopy procedures and FNA biopsy via EBUS by ROSE method.

Complications related to endobronchial ultrasound biopsy is expected to hamper the market growth

Sedation complications include hypoxemia and hypotension, whereas bronchoscopy complications include bronchospasm, laryngospasm, nausea, vomiting, bleeding due to scope trauma, cardiac arrhythmias, and vasovagal syncope. Pneumothorax and bleeding are two complications associated with EBUS-TBNA.Furthermore, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a sophisticated technique that requires expertise and experience to implement effectively. Evidence-based procedures for training pulmonologists in the area of EBUS-TBNA are required; however, there are currently no such accepted or standard techniques for assessing EBUS technical skills and competencies, which would hamper the market's growth. And the high cost of these medical devices and a lack of proper reimbursement policies in emerging economies may potentially restrain the market.

COVID-19 Impact Analysis

Bronchoscopy is widely regarded as an aerosol-generating procedure (AGP). This, combined with the prioritization of preserving limited personal protective equipment (PPE) stock, resulted in unanimous agreement that non-urgent bronchoscopy be postponed until the coronavirus disease 2019 (COVID19) pandemic had passed.Bronchoscopy is used in patients with suspected or confirmed COVID-19 infection, according to current guidelines. Patients continue to present with symptoms and findings unrelated to COVID-19 infection throughout the pandemic but due to suspected lung cancer. Bronchoscopy remains a potentially harmful procedure in these patients. Because of the medical field's focus on treating COVID-19, funding for R&D activities related to endobronchial ultrasound biopsy has been reduced. It has been neglected, resulting in a negative impact on the endobronchial ultrasound biopsy market.

The higher prevalence of the SARS-CoV-2 virus in people with lung disorders, on the other hand, is associated with higher mortality and morbidity rates, which is expected to drive up market demand for endobronchial ultrasound biopsy devices.

Segment Analysis

The transbronchial aspirational needles segment is expected to dominate the global endobronchial ultrasound biopsy market

Transbronchial needle aspiration (TBNA) is a technique for obtaining cellular material by passing a needle through the bronchial wall. It is used to obtain tissue from lesions of the lung or hilar/mediastinal system that are close to the endobronchial tree.TBNA allows for the minimally invasive diagnosis and staging of pulmonary, hilar, and mediastinal lesions (particularly lung cancer) and evaluating these areas for non-malignant pathology such as sarcoidosis. Despite these benefits, TBNA has previously been an underutilized technique, a trend that may change as trainees gain more experience with the procedure.The recent advancement of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) reignited interest and confidence in TBNA. Conventional transbronchial needle aspiration refers to TBNA without EBUS (C-TBNA).

For instance, the role of Boston Scientific company's eXcelon Transbronchial Aspiration Needle is designed to aspiration bronchial tree lesions in the carinal, paratracheal, and hilar regions where biopsy forceps cannot obtain a submucosal sample.Technological advances and widespread use of these needles in gastroenterology and pulmonology are expected to drive the market in the forecast period.

Geographical Analysis

North America region accounted for the largest market share in the global endobronchial ultrasound biopsy market

An increase in lung cancer and chronic respiratory disease, product launches and FDA approval in this region is expected to drive the market growth.

According to The American Cancer Society in the United States, in 2021, there will be approximately 235,760 new cases of lung cancer each year (119,100 in men and 116,660 in women). Lung cancer claimed the lives of approximately 131,880 people (69,410 in men and 62,470 in women). Lung cancer primarily affects the elderly. Most of the people diagnosed with lung cancer are 65 or older. Only a small number of people diagnosed are under 45. It is the leading cause of cancer death in both men and women, accounting for nearly 25% of all cancer deaths.Bronchoscopy with EBUS (endobronchial ultrasound) is a procedure used to diagnose various types of lung disorders, such as inflammation, infections, or cancer. And with the increasing incidence of lung cancer, the market is expected to grow in the forecast period.

On February 20, 2019, The US Food and Drug Administration (FDA) approved Intuitive Surgical Inc.'s Ion endoluminal system for minimally invasive biopsy in the peripheral lung.

Competitive Landscape

The global endobronchial ultrasound biopsy market is moderately competitive with major key players' FDA approvals, company megers and product launches.

The key players in the global endobronchial ultrasound biopsy market are Medtronic plc, Olympus Corporation, Clinodevice, CONMED Corporation, Medi-Globe Corporation, Boston Scientific Corporation, Veran Medical Technologies, Simbionix USA Corporation, FUJIFILM Corporation and Cook Group Incorporated.

Olympus Corporation

  • Overview: Olympus Corporation is a Japanese optics and reprography product manufacturer. On October 12, 1919, Olympus was founded, initially specializing in microscopes and thermometers. Olympus controls roughly 70% of the global endoscope market.
  • Product Portfolio: The company's BF-UC190F, when used with the versatile Olympus ViziShot EBUS-TBNA needle portfolio, enables physicians to access and sample difficult-to-reach targets such as lymph nodes in the mediastinum (4L) and hilum (10R). Powerful Scope Angulation, Compact Distal Tip, Steeper Puncture Angle, and Enhanced Endoscopic View are key design features of the BF-UC190F that enable improved access and sampling.
  • Key Development: On May 12, 2021, The BF-UC190F endobronchial ultrasound (EBUS) bronchoscope cleared FDA approval for market launch, the newest addition to Olympus' robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.

Why Purchase the Report?

  • Visualize the composition of the global endobronchial ultrasound biopsy market segmentation by product type, by application and end-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in global endobronchial ultrasound biopsy market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global endobronchial ultrasound biopsy market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global endobronchial ultrasound biopsy market report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Endobronchial Ultrasound Biopsy Market- By Product Type

  • Transbronchial Aspiration Needles
  • Biopsy Needles
  • Biopsy Forceps
  • Other

Global Endobronchial Ultrasound Biopsy Market- By Application

  • Lung Cancer Diagnosis
  • Lung Infection Diagnosis
  • Other

Global Endobronchial Ultrasound Biopsy Market- By End-User

  • Hospitals
  • Diagnostics Laboratories
  • Other

Global Endobronchial Ultrasound Biopsy Market- By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Global Endobronchial Ultrasound Biopsy Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Endobronchial Ultrasound Biopsy Market- Market Definition and Overview

3. Global Endobronchial Ultrasound Biopsy Market- Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Endobronchial Ultrasound Biopsy Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancements in EBUS devices diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. Complications related to endobronchial ultrasound biopsy
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Endobronchial Ultrasound Biopsy Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Endobronchial Ultrasound Biopsy Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Endobronchial Ultrasound Biopsy Market- By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Transbronchial Aspiration Needles*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Biopsy Needles
  • 7.4. Biopsy Forceps
  • 7.5. Other

8. Global Endobronchial Ultrasound Biopsy Market- By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Lung Cancer Diagnosis
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Lung Infection Diagnosis
  • 8.4. Other

9. Global Endobronchial Ultrasound Biopsy Market- By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Diagnostics Laboratories
  • 9.4. Other

10. Global Endobronchial Ultrasound Biopsy Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.5.1. U.S.
      • 10.2.5.2. Canada
      • 10.2.5.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.5.1. Brazil
      • 10.4.5.2. Argentina
      • 10.4.5.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.5.1. China
      • 10.5.5.2. India
      • 10.5.5.3. Japan
      • 10.5.5.4. Australia
      • 10.5.5.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Global Endobronchial Ultrasound Biopsy Market- Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Global Endobronchial Ultrasound Biopsy Market- Company Profiles

  • 12.1. Olympus Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Medtronic plc
  • 12.3. CLINODEVICE
  • 12.4. CONMED Corporation
  • 12.5. Medi-Globe Corporation
  • 12.6. Boston Scientific Corporation
  • 12.7. Veran Medical Technologies
  • 12.8. Simbionix USA Corporation
  • 12.9. FUJIFILM Corporation
  • 12.10. Cook Group Incorporated (*LIST NOT EXHAUSTIVE)

13. Global Endobronchial Ultrasound Biopsy Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us